Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Interim Management Statement

29 Jan 2021 10:37

RNS Number : 3696N
Unicorn AIM VCT PLC
29 January 2021
 

Unicorn AIM VCT plc ("the Company")

Interim Management Statement 

For the period from 1 October 2020 to 31 December 2020

 

Introduction

This voluntary Interim Management Statement (IMS) covers the three month period ended 31 December 2020, together with relevant information up to the date of publication. 

 

Investment Objective

The Company's objective is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maintaining a steady flow of dividend distributions to Shareholders from the income as well as capital gains generated by the portfolio.

 

It is also the objective that the Company should continue to qualify as a Venture Capital Trust ("VCT"), so that Shareholders benefit from the taxation advantages that this brings. To achieve this, at least 80% for accounting periods commencing on or after 6 April 2019 (previously 70%) of the Company's total assets are to be invested in qualifying investments of which 70% by VCT value (30% in respect of investments made before 6 April 2018 from funds raised before 6 April 2011) must be in ordinary shares, which carry no preferential rights (save as permitted under VCT rules) to dividends or return of capital and no rights to redemption.

 

Performance  

The performance of the Company's diverse portfolio of investments, has been largely positive during the first quarter of the Company's current financial year. Net asset value per share increased significantly, as many of the companies held in the portfolio issued encouraging trading updates which, in turn, triggered some impressive share price gains.

 

As at 31 December 2020, the unaudited net asset value was 204.5 pence per share, which represents an increase of +14.5% on the audited closing net asset value of 178.6 pence per share as at 30 September 2020. UK equity indices also continued their recovery from the significant equity market correction experienced during March 2020, with the FTSE AIM All-Share Index generating a total return of +20.9%, while the FTSE AllShare Index delivered a total return of +12.6% over the same period.

 

The portfolio remains predominantly composed of investments in businesses listed on the Alternative Investment Market (AIM). Many of these investee companies are relatively mature and, as such, most have them have remained profitable throughout the difficulties experienced during 2020.

 

Encouragingly, the pipeline of investment opportunities has strengthened since the start of October, and all key HMRC tests continued to be met. At the period end, an estimated 85.4% of total assets (assessed in accordance with VCT rules) were invested in VCT qualifying companies.

 

Despite the increased risks associated with early-stage investment and the uncertainty created by the ongoing pandemic, the Investment Manager is confident that the portfolio, as a whole, offers the prospect of delivering attractive total returns over the longer term.

 

Material Transactions

During the period under review, four new VCT qualifying investments, costing £6.3 million, were completed. No follow-on VCT qualifying investments were made.

 

Approximately £0.4 million was raised from the partial disposal of one holding during the period. In addition, one holding was disposed of in full, realising proceeds of approximately £1.4 million. The usual purpose of such disposals is threefold; to ensure stock specific risk is contained, to lock in capital profits for future distribution to shareholders via dividend payments and to help manage liquidity requirements.

 

Top Ten VCT Qualifying Holdings as at 31 December 2020

Stock

% of fund

Interactive Investor

10.7%

Hasgrove

9.6%

Abcam

6.4%

MaxCyte Inc

5.3%

Tracsis

3.5%

Anpario

3.2%

Tristel

2.9%

Surface Transforms

2.7%

Cohort

2.5%

Mattioli Woods

2.4%

Total

49.2%

 

Share Buy-Backs

During the period from 1 October to 31 December 2020, the Company bought back 770,517 of its own Ordinary Shares for cancellation, at an average price of 162 pence per share. As at 31 December 2020, there were 144,962,024 Ordinary Shares in issue. After the period end, a further 131,796 Ordinary Shares were purchased for cancellation at a price of 174.5 pence per share.

 

Dividends & Annual General Meeting

As previously advised, the Board declared a final dividend of 3.5 pence per share in respect of the Company's financial year ended 30 September 2020. This final dividend will be paid on 11 February 2021 to Shareholders who were on the register on 8 January 2021, subject to receiving approval from shareholders at the Annual General Meeting of the Company, which is to be held on 4 February 2021, in a closed format due to the ongoing Covid-19 pandemic.

 

Material Events

There were no material events during the period under review.

An Offer for Subscription, to raise up to £15 million of new capital, opened on 28 January 2021 and will close for applications on 29 March 2021, or earlier, if fully subscribed.

 

Chris Hutchinson

Director, Unicorn Asset Management

 

29 January 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFZGZMGLKGMZM
Date   Source Headline
12th Aug 202110:41 amRNSIssue of Equity
4th Aug 20219:38 amRNSNet Asset Value(s)
2nd Aug 202112:06 pmRNSTotal Voting Rights
23rd Jul 20213:21 pmRNSInterim Management Statement
13th Jul 20216:11 pmRNSTransaction in Own Shares
6th Jul 20213:26 pmRNSNet Asset Value(s)
3rd Jun 20215:32 pmRNSNet Asset Value(s)
1st Jun 202111:49 amRNSTotal Voting Rights
25th May 20215:27 pmRNSTransaction in Own Shares
20th May 202110:00 amRNSNet Asset Value(s)
18th May 20214:20 pmRNSHalf-year Report
7th May 20219:45 amRNSNet Asset Value(s)
8th Apr 202111:57 amRNSIssue of Equity
6th Apr 20219:32 amRNSNet Asset Value(s)
1st Apr 202110:29 amRNSTotal Voting Rights
10th Mar 20212:15 pmRNSTransaction in Own Shares
3rd Mar 20215:18 pmRNSNet Asset Value(s)
1st Mar 202110:50 amRNSTotal Voting Rights
22nd Feb 202110:20 amRNSTotal Voting Rights
22nd Feb 202110:18 amRNSDirector/PDMR Shareholding
19th Feb 20213:27 pmRNSIssue of Equity
17th Feb 202110:01 amRNSNet Asset Value(s)
11th Feb 20215:33 pmRNSOffer Update - Close of Applications for Offer
11th Feb 202111:28 amRNSIssue of Equity
11th Feb 20217:00 amRNSTransaction in Own Shares
4th Feb 202112:38 pmRNSResult of AGM
2nd Feb 20214:01 pmRNSNet Asset Value(s)
1st Feb 202110:25 amRNSTotal Voting Rights
29th Jan 202110:37 amRNSInterim Management Statement
28th Jan 202110:54 amRNSOffer for Subscription and Issue of Prospectus
8th Jan 20215:44 pmRNSTransaction in Own Shares
6th Jan 20219:53 amRNSNet Asset Value(s)
4th Jan 202110:24 amRNSTotal Voting Rights
21st Dec 20205:34 pmRNSTransaction in Own Shares
17th Dec 20204:33 pmRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSFinal Results
10th Dec 20204:53 pmRNSNet Asset Value(s)
7th Dec 20203:53 pmRNSIntention to launch an Offer
12th Nov 20207:00 amRNSNet Asset Value(s)
21st Oct 202010:18 amRNSNet Asset Value(s)
1st Oct 202011:08 amRNSTotal Voting Rights
24th Sep 202010:24 amRNSDirector Declaration
11th Sep 20204:10 pmRNSTransaction in Own Shares
8th Sep 202010:19 amRNSNet Asset Value(s)
8th Sep 20209:52 amRNSDirector Declaration
1st Sep 20209:36 amRNSTotal Voting Rights
17th Aug 20206:14 pmRNSTransaction in Own Shares
12th Aug 20201:04 pmRNSIssue of Equity
6th Aug 202012:43 pmRNSNet Asset Value(s)
3rd Aug 202011:02 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.